About BioPharmX
BioPharmX Corporation (NYSE American: BPMX) is a specialty pharmaceutical company focused on developing products that treat chronic dermatologic conditions that are not being adequately addressed or those where current therapies and approaches are suboptimal. The Company is developing prescription products through its proprietary HyantX delivery system for dermatology indications. BioPharmX has two lead products in development, BPX-04 for the treatment of papulopustular rosacea and BPX-01 for the treatment of acne vulgaris.
Company Details
1M-5M
Biotechnology Research
11-50 employees
Public Company
San Jose, CA
United States
Frequently Asked Questions about
What is BioPharmX's industry?
BioPharmX operates in the Biotechnology Research industry and is headquartered in United States.
How many employees does BioPharmX have?
BioPharmX has approximately 11-50 employees employees.
Where is BioPharmX's based?
BioPharmX is based in San Jose, CA, United States.
Is BioPharmX publicly listed?
Yes. BioPharmX is a publicly traded company.
How can I contact BioPharmX's investor relations team?
You can reach BioPharmX’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Find verified emails and phone numbers for professionals like those at
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
Find verified emails at this company
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.